GlaxoSmithKline (GSK) is in the businesses of pharmaceuticals, vaccines and consumer healthcare. GSK was formerly known as Glaxo Wellcome. The company has centres in the U.S. Belgium, China and the U.K. GSK’s products include treatments for migraines, heart failure and cancer. The company produces vaccines for hepatitis A, hepatitis B and whooping cough. GSK also has dental-care products, over-the-counter medications, nutritional drinks and smoking-cessation products.
GSK’s portfolio includes medicines in respiratory conditions and HIV. Their R&D is focused on the immune system using genetics approaches.
GSK is partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to use their adjuvant platform to improve immune responses to vaccines, including a collaboration with University of Queensland, Australia, which is developing a potential COVID-19 vaccine. GlaxoSmithKline (GSK) is partnering with Clover Biopharmaceuticals to provide its pandemic adjuvant system for preclinical studies with Clover’s Covid-19 S-Trimer since an adjuvant may reduce the amount of vaccine protein required.
Can CRISPR help us do better detective work in the fight on cancer?
November 22, 2021
GSK - Our story
September 12, 2019
Our consumer healthcare products | GSK
- BiotechnologyBiotechnology in a broad sense includes the use of living systems and organisms, as well as their parts for the development or production of products.
- COVID-19COVID-19 is the abbreviated name for coronavirus disease 2019, a respiratory disease caused by a novel coronavirus strain called SARS-CoV-2. COVID-19 was first detected in Wuhan City, China and the outbreak was declared a pandemic on March 11, 2020 by the World Health Organization.